| benserazide | <chemical> An inhibitor of dopa decarboxylase that does not enter the central nervous system. It is often given with levodopa in the treatment of parkinsonism to prevent the conversion of levodopa to dopamine in the periphery, thereby increasing the amount that reaches the central nervous system and reducing the required dose. It has no antiparkinson actions when given alone. Pharmacological action: antiparkinson agents, dopamine agents, enzyme inhibitors. Chemical name: DL-Serine, 2-((2,3,4-trihydroxyphenyl)methyl)hydrazide (12 Dec 1998) |
|---|
Synonyms : DL-Serine 2-((2, 3, 4-trihydroxyphenyl)methyl)hydrazide, Ro 4-4602, Seryltrihydroxy Benzylhydrazine, Benzylhydrazine, Seryltrihydroxy, Ro 4 4602, Ro 44602
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|---|---|---|---|
|
마도파정125mg - 새창
|
한국로슈 |
A44000461 | Benserazide HCl, Levodopa | 전문의약품 | 삭제 |
|
마도파확산정125mg - 새창
|
Roche |
E01840311 | Benserazide HCl, Levodopa | 전문의약품 | 급여 |
|
마도파에취비에스캅셀 - 새창
|
Roche |
E01840021 | Benserazide HCl, Levodopa | 전문의약품 | 급여 |
|
마도파정 - 새창
|
한국로슈 |
A44000031 | Benserazide HCl, Levodopa | 전문의약품 | 삭제 |
|
도파자이드에이정 - 새창
|
한국유니온제약 |
A12202171 | Benserazide HCl, Levodopa | 전문의약품 | 삭제 |
|
벤세파정 - 새창
|
미래제약 |
A20652281 | Benserazide HCl, Levodopa | 전문의약품 | 삭제 |
|
로도벤정 - 새창
|
명문제약 |
A31803491 | Benserazide HCl, Levodopa | 전문의약품 | 삭제 |
|
알비피정 - 새창
|
한국프라임제약 |
A62752341 | Benserazide HCl, Levodopa | 전문의약품 | 급여 |
|
마도파정125 - 새창
|
한국로슈 |
W21840131 | Benserazide HCl, Levodopa | 전문의약품 | 급여 |
|
마도파정 - 새창
|
한국로슈 |
W21840151 | Benserazide HCl, Levodopa | 전문의약품 | 급여 |
| benserazide |
The decarboxylase inhibitor that is co-administered with levodopa in Madopar ?br>
출처: www.parkinsonsdisease.com/lwp/glossary.htm
|
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|